A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Kelli M MoneyAshmanie MahatooSoleil SamaanPria AnandUrsela BaberMary BaileyRohit BakshiAndrew BouleyAaron BowerJonathan CahillMaria K HoutchensJoshua KatzEllen LathiElle LevitErin E LongbrakeMatthew McAdamsSalvatore NapoliPooja RaibagkarPeter WadeJacob A SloanePublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
The case fatality and hospitalization rates in our cohort were similar to those found in MS and general population COVID-19 cohorts within the region. Hospitalization was associated with increased disability, age, and comorbidities but not disease-modifying therapy use.